Type 2 Diabetes Clinical Trial
— GSHOfficial title:
Effects of the "Glutathione Support for Health (GSH)" Plan on Glutathione Status in Type 2 Diabetes
| NCT number | NCT04386187 |
| Other study ID # | 180215 |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | July 28, 2020 |
| Est. completion date | April 2, 2021 |
| Verified date | January 2022 |
| Source | University of California, San Diego |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The purpose of this research study is to find out whether certain plant-based foods may be beneficial for individuals with type 2 diabetes. To meet the goal, study participants will be fed known amounts of foods and nutrients. Before and after participants have eaten the food, they will self-measure height, weight, and waist circumference and study staff will administer questionnaires. Blood samples will be taken at a local lab to measure blood sugar and blood lipids.All study appointments will be conducted online.
| Status | Completed |
| Enrollment | 12 |
| Est. completion date | April 2, 2021 |
| Est. primary completion date | April 2, 2021 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years to 65 Years |
| Eligibility | Inclusion Criteria: - Men and women - Ages 18 to 65 - Type 2 diabetes - Free of self-reported acute and confounding chronic diseases (e.g., heart failure, kidney disease, liver disease, gastrointestinal disorder) based on a standardized medical history questionnaire - Free of alcoholism, smoking and major cardiovascular event with the past 6 months - Not on insulin to help manage diabetes - Planning on staying in the San Diego area for the next 6 months - Willing to select plant-based foods from a "menu" and eat the selected foods provided by the study team - Have access to the internet and a computer - Willing to view 4 weekly educational classes online, followed by periodic telephone and email contacts - Agree to schedule and complete periodic questionnaires and measurements during up to four total online appointments Exclusion Criteria: - Alcoholism, smoking and recent cardiovascular events - Individuals will be excluded if they report any dietary restrictions, allergies or preferences - Unsuitability based on screening visit |
| Country | Name | City | State |
|---|---|---|---|
| United States | University of California, San Diego | San Diego | California |
| Lead Sponsor | Collaborator |
|---|---|
| University of California, San Diego |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Other | Total glutathione | Total glutathione concentration in the blood | 24 weeks | |
| Other | gamma-glutamyltransferase (GGT) | Measure of glutathione demand in the blood | 24 weeks | |
| Other | Fasting insulin | Plasma insulin concentration while fasting | 24 weeks | |
| Other | Fasting glucose | Serum glucose concentration while fasting | 24 weeks | |
| Other | Hemoglobin A1c | Measure of glycemic control | 24 weeks | |
| Other | Homeostasis Assessment Index of Insulin Resistance (HOMA-IR) | Estimate of insulin resistance | 24 weeks | |
| Other | Low density lipoprotein concentration (LDL-c) | concentration of LDL lipoproteins in serum | 24 weeks | |
| Other | High density lipoprotein concentration (HDL) | concentration of HDL lipoproteins in serum | 24 weeks | |
| Other | Triglycerides | concentration of triglycerides in serum | 24 weeks | |
| Primary | Total glutathione | Total glutathione concentration in the blood | 12 weeks | |
| Primary | gamma-glutamyltransferase (GGT) | Measure of glutathione demand in the blood | 12 weeks | |
| Secondary | Fasting glucose | Serum glucose concentration while fasting | 12 weeks | |
| Secondary | Fasting insulin | Plasma insulin concentration while fasting | 12 weeks | |
| Secondary | Hemoglobin A1c | Measure of glycemic control | 12 weeks | |
| Secondary | Homeostasis Assessment Index of Insulin Resistance (HOMA-IR) | Estimate of insulin resistance | 12 weeks | |
| Secondary | Low density lipoprotein concentration (LDL-c) | concentration of LDL lipoproteins in serum | 12 weeks | |
| Secondary | High density lipoprotein concentration (HDL) | concentration of HDL lipoproteins in serum | 12 weeks | |
| Secondary | Triglycerides | concentration of triglycerides in serum | 12 weeks |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05219994 -
Targeting the Carotid Bodies to Reduce Disease Risk Along the Diabetes Continuum
|
N/A | |
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Completed |
NCT02284893 -
Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone
|
Phase 3 | |
| Completed |
NCT04274660 -
Evaluation of Diabetes and WELLbeing Programme
|
N/A | |
| Active, not recruiting |
NCT05887817 -
Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR)
|
Phase 4 | |
| Active, not recruiting |
NCT05566847 -
Overcoming Therapeutic Inertia Among Adults Recently Diagnosed With Type 2 Diabetes
|
N/A | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Completed |
NCT04965506 -
A Study of IBI362 in Chinese Patients With Type 2 Diabetes
|
Phase 2 | |
| Recruiting |
NCT06115265 -
Ketogenic Diet and Diabetes Demonstration Project
|
N/A | |
| Active, not recruiting |
NCT03982381 -
SGLT2 Inhibitor or Metformin as Standard Treatment of Early Stage Type 2 Diabetes
|
Phase 4 | |
| Completed |
NCT04971317 -
The Influence of Simple, Low-Cost Chemistry Intervention Videos: A Randomized Trial of Children's Preferences for Sugar-Sweetened Beverages
|
N/A | |
| Completed |
NCT04496154 -
Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood
|
N/A | |
| Completed |
NCT04023539 -
Effect of Cinnamomum Zeylanicum on Glycemic Levels of Adult Patients With Type 2 Diabetes
|
N/A | |
| Recruiting |
NCT05572814 -
Transform: Teaching, Technology, and Teams
|
N/A | |
| Enrolling by invitation |
NCT05530356 -
Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
|
||
| Completed |
NCT03960424 -
Diabetes Management Program for Hispanic/Latino
|
N/A | |
| Completed |
NCT04097600 -
A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets
|
Phase 1 | |
| Completed |
NCT05378282 -
Identification of Diabetic Nephropathy Biomarkers Through Transcriptomics
|
||
| Active, not recruiting |
NCT06010004 -
A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT03653091 -
Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes
|
N/A |